Kolexia
Dahan Laetitia Gastro-entérologie
Dahan Laetitia
Gastro-entérologie
Hôpital La Timone
Marseille, France
225 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Carcinomes Tumeurs colorectales Adénocarcinome Tumeurs du pancréas Tumeurs de l'oesophage Métastase tumorale Carcinome épidermoïde Tumeurs de l'estomac Tumeurs du foie

Collaborateurs

Voir plus
Seitz Jean-Francois
Seitz Jean-Francois
Hôpital La Timone, Marseille, France
Tougeron David
Tougeron David
Hôpital La Miletrie, Poitiers, France
Lepage Come
Lepage Come
Hôpital François Mitterrand, Dijon, France
Francois Eric
Francois Eric
Centre Antoine Lacassagne, Nice, France

Industries

Voir plus
Servier
9 collaboration(s)
Dernière en 2023
Pierre Fabre
4 collaboration(s)
Dernière en 2022
Advanced Accelerator Applications
4 collaboration(s)
Dernière en 2023
Mylan Medical
3 collaboration(s)
Dernière en 2022

Dernières activités

Voir plus
ASPIRE: A Randomized, Double-Blind, Placebo-Controlled Study of Nab-Paclitaxel and Gemcitabine With or Without SBP-101 in Subjects Previously Untreated for Metastatic Pancreatic Ductal Adenocarcinoma
Essai Clinique (Panbela Therapeutics, Inc.)   12 mars 2024
SCARCE: A Non-comparative Randomized 2:1 Phase II Study of Docetaxel, Cisplatin, and 5-fluorouracil in Combination or Not With Atezolizumab in Patients With Metastatic or Unresectable Locally Advanced Squamous Cell Anal Carcinoma
Essai Clinique (Roche)   08 mars 2024
PROTECT: PReoperative Chemoradiation With Paclitaxel-carboplatin or With Fluorouracil-oxaliplatine-acide Folinique (FOLFOX) for Resectable Esophageal and Junctional Cancer - A Randomized Phase II Trial
Essai Clinique (Centre Oscar-Lambret)   26 février 2024
A Phase 1/2, Study Evaluating the Safety, Tolerability, PK, and Efficacy of Sotorasib (AMG 510) in Subjects With Solid Tumors With a Specific KRAS Mutation (CodeBreaK 100): A Phase 1/2, Open-label Study Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of Sotorasib (AMG 510) Monotherapy in Subjects With Advanced Solid Tumors With KRAS p.G12C Mutation and Sotorasib (AMG 510) Combination Therapy in Subjects With Advanced NSCLC With KRAS p.G12C Mutation (CodeBreaK 100)
Essai Clinique (Amgen)   22 février 2024
IMMUNO-BIL: Durvalumab Plus Tremelimumab Combination Immunotherapy With or Without Weekly Paclitaxel in Patients With Advanced Biliary Tract Carcinoma (BTC) After Failure of Platinum-based Chemotherapy: a Randomized Non-comparative Two-arm Phase II Study
Essai Clinique (AstraZeneca)   03 janvier 2024
INTERACT-ION: Ezabenlimab (BI 754091) and mDCF (Docetaxel, Cisplatin and 5-fluorouracil) Followed by Chemoradiotherapy in Patients With Stage III Squamous Cell Anal Carcinoma. A Phase II Study
Essai Clinique (Boehringer Ingelheim)   21 décembre 2023
SAFIR-ABC10: Molecular Targeted Maintenance Therapy Versus Standard of Care in Advanced Biliary Cancer: an International, Randomised, Controlled, Open-label, Platform Phase 3 Trial
Essai Clinique (Taiho Oncology, Inc.)   15 novembre 2023
1520P Perioperative treatment in resectable gastric cancer with spartalizumab combined with fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT): The GASPAR phase II trial
Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023.   01 octobre 2023
NIPISAFE: Analysis of the Efficacy and Safety of Two Combination Treatment Regimens of Nivolumab and Ipilimumab in Patients With dMMR and / or MSI Metastatic Colorectal Cancer: A GERCOR Open-label, Randomized, Non-comparative, Two-stage Phase II Trial (NIPISAFE).
Essai Clinique (BMS)   27 septembre 2023
GRECCAR14: Multicentric Phase II-III Study Evaluating the Tailored Management of Locally-advanced Rectal Carcinoma After a Favorable Response to Induction Chemotherapy
Essai Clinique (Institut du Cancer de Montpellier)   26 septembre 2023